EP08.02-042 EGFR-TKI +/- Antiangiogenics for EGFR-mutated Advanced NSCLC
Autor: | da Silva, L.L. 1, Matsas, S. 2, Aguiar, P., Jr. 3, Taveira, G.M.T. 3, Barcelos, I.F. 3, Lopes, G.L., Jr. 4 |
---|---|
Zdroj: | In Journal of Thoracic Oncology September 2022 17(9) Supplement:S416-S417 |
Databáze: | ScienceDirect |
Externí odkaz: |